NCT01996748View on ClinicalTrials.gov

Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema

PHASE3CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2013

Conditions
Otic Eczema
Interventions
DRUG

DF277

Two administrations daily for 7 days

DRUG

Placebo

Two administrations daily for 7 days

Trial Locations (1)

08950

Laboratorios SALVAT, S.A., Esplugues de Llobregat

Sponsors

Lead Sponsor

Salvat
All Listed Sponsors
lead

Salvat

INDUSTRY

NCT01996748 - Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema | Biotech Hunter | Biotech Hunter